Skip to main content

Table 1 Demographics of participants with NGJH (Non Generalised Joint Hypermobility), GJH (Generalised Joint Hypermobility) and GJHS (GJH including shoulder joint hypermobility)

From: Generalised joint hypermobility and shoulder joint hypermobility, – risk of upper body musculoskeletal symptoms and reduced quality of life in the general population

Variable

All

(n = 989)

NGJH

(n = 689)

GJH

(n = 300)

p-value

GJHS

(n = 51)

p-value

Women, % (no.)

55.9 (553)

47.3 (326)

75.7 (227)

<0.001*

76.5 (39)

<0.001*

Age, median (IQR)

50 (40–57)

50 (41–57)

48 (38–55.5)

0.025

46 (34–57)

0.145

BMI (Kg/m2), median (IQR)

25.4 (22.9–28.1)

25.5 (23.1–28.1)

25.1 (22.5–28.1)

0.151

24.5 (21.2–29.0)

0.284

Work-related status, % (no.)

   

0.188

 

0.149

 Employed

71.2 (704)

72.3 (498)

68.7 (206)

 

54.9 (28)

 

 Un-employed

3.74 (37)

3.34 (23)

4.67 (14)

 

3.92 (2)

 

 Student

3.74 (37)

3.19 (22)

5.00 (15)

 

5.88 (3)

 

 Absent because of illness

1.82 (18)

1.60 (11)

2.33 (7)

 

3.92 (2)

 

 Early retired

3.94 (39)

3.19 (22)

5.67 (17)

 

7.84 (4)

 

 Retired

4.15 (41)

4.06 (28)

4.33 (13)

 

7.84 (4)

 

 Other

11.43 (113)

12.3 (85)

9.33 (28)

 

15.7 (8)

 

EuroQol VAS, median (IQR)

85 (75–90)

85 (75–90)

80 (70–90)

<0.001*

75 (60–90)

<0.001*

EQ-5D Index, median (IQR)

0.86 (0.77–1)

0.86 (0.78–1)

0.82 (0.74–0.86)

<0.001*

0.79 (0.67–0.86)

<0.001*

  1. *Indicates a statistical significant difference (p-value <0.025) between participants with NGJH and GJH, and between NGJH and GJHS